查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475885

动物骨科植入物市场：依地区（北美、欧洲、亚太地区、拉丁美洲、中东非洲）：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031

Orthopedic Veterinary Implants Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 132 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究发布了一份对全球动物骨科植入物市场进行深入分析的报告。 该报告提供了关键市场动态的全面见解，包括成长动力、课题、新兴趋势和关键市场发展。 该研究涵盖2024年至2031年期间，为利害关係人做出明智决策和製定策略计画提供有价值的资讯。

全球动物骨科植入物市场预计将从 2024 年的 29 亿美元增至 2031 年的 53 亿美元，预测期内复合年增长率为 9%。

关键见解

  • 兽用骨科植入物市场规模（2024 年预估）：29 亿美元
  • 市场预测值（2031 年预测）：53 亿美元
  • 全球市场成长率（2024-2031 年复合年增长率）：9%

动物骨科植入物市场-调查范围：

宠物拥有量的增加和对先进兽医治疗的投资意愿不断增强是动物骨科植入物市场的主要驱动力。 随着宠物主人为他们的动物寻求优质的医疗护理，对用于治疗骨折、关节疾病和退化性疾病等疾病的骨科植入物的需求不断增长。 植入物设计和材料的技术进步正在带来更有效的治疗并推动市场发展。

此外，兽医行业对提供专业护理的关注增加了对熟练骨科医生和先进设备的需求，从而推动了新产品和治疗方法的开发。 此外，提供骨科服务的兽医院和诊所数量的增加也促进了市场的扩张。

推动市场成长的因素：

有几个因素正在推动动物骨科植入物市场的成长。 由于宠物数量的增加以及宠物的人性化，越来越多的宠物主人正在寻求专业治疗。 这一趋势得到了可支配收入增加的支持，这使得宠物主人能够负担得起更复杂和更昂贵的手术。

技术进步也发挥着重要作用，钛和不銹钢等植入材料的创新创造了更耐用和生物相容性的产品。 微创手术技术的采用可以缩短宠物的恢復时间并降低风险。 此外，兽医和宠物主人已经意识到骨科植入物的好处，推动了市场的成长。

市场限制因素：

儘管成长，动物骨科植入物市场仍面临课题。 矫形手术和植入物的高昂成本让一些所有者望而却步，并限制了他们进入市场。 在发展中国家尤其如此，这些国家获得兽医保健的机会很差且收入水准较低。 这些复杂的手术需要专门的培训，而熟练的骨科兽医的数量有限也阻碍了这项培训。 有关产品审批和动物福利的监管障碍也可能减缓市场扩张。 此外，原物料价格的波动会影响植入物的製造成本并影响市场动态。

市场机会：

动物骨科植入物市场存在多种成长和扩张机会。 公司可以专注于开发具有成本效益的植入物，以服务更广泛的客户，特别是在新兴市场。 此外，宠物保险的日益普及将使宠物主人能够负担昂贵的手术，从而促进市场成长。 兽医学校、研究机构和植入物製造商之间的合作研究促使了创新产品和技术的开发，从而推动了市场成长。 人们对动物福利意识的不断提高以及对优质兽医护理的需求预计也将为市场参与者创造新的机会。

本报告涵盖的主要问题

  • 动物骨科植入物市场的预期复合年增长率是多少？
  • 推动动物骨科植入物市场成长的关键因素是什么？
  • 哪个地区在动物骨科植入物市场中占有最大的市占率？
  • 全球动物骨科植入物市场的主要参与者有哪些？
  • 主要参与者采取哪些策略来维持动物骨科植入物市场的成长？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第三章市场动态

  • 宏观经济因素
  • 促进因素
    • 供给面因素
    • 需求方驱动因素
  • 抑制因素
  • 机会
  • 趋势

第四章主要内容

  • 狗的关节炎
  • 美国的日常护理
  • 宠物护理

第五章全球动物骨科植体市场分析（金额）

  • 过去的市场（金额）分析，2019-2023 年
  • 2024-2031 年当前及未来市场（金额）预测

第 6 章全球动物骨科植体市场分析、产品类型

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2031 年当前与未来市场规模（金额）分析与预测
    • 全膝关节置换术 (TKR)
    • 全髋关节置换术 (THR)
    • 创伤固定
    • 胫骨结节推进 (TTA) 植体
    • 胫骨平台整平截骨术 (TPLO) 植入物
    • 高级锁定板系统 (ALPS)
    • 全手肘关节置换术 (TER)
  • 依产品类型进行市场吸引力分析

第 7 章最终使用者的全球动物骨科植入物市场分析

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2031 年当前与未来市场规模（金额）分析与预测
    • 动物医院
    • 兽医诊所
  • 最终用户的市场吸引力分析

第 8 章依地区划分的全球动物骨科植入物市场分析

  • 简介
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2031 年目前市场规模（金额）分析与预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 依地区划分的市场吸引力分析

第九章北美动物骨科植入物市场分析

第10章拉丁美洲动物骨科植体市场分析

第11章欧洲动物骨科植体市场分析

第十二章亚太动物骨科植体市场分析

第十三章中东与非洲动物骨科植体市场分析

第14章竞争分析

  • 竞争对手仪表板
  • 衝突详情
    • Vet Implants
    • scil animal care company GmbH
    • KYON Pharma, Inc.
    • Everost Inc.
    • BioMedtrix, LLC
    • Integra LifeSciences
    • RITA LEIBINGER MEDICAL GmbH &Co. KG
    • B. Braun Melsungen AG
    • DePuy Synthes（Sub. Johnson &Johnson Services, Inc.）
    • Intrauma SpA
    • Surgical Holdings
    • Ortho Max Manufacturing Company Pvt. Ltd. Novartis AG

第 15 章先决条件与使用的缩写

第十六章研究方法

简介目录
Product Code: PMRREP22939

Persistence Market Research has released an in-depth analysis examining the global Orthopedic Veterinary Implants Market. This report provides comprehensive insights into key market dynamics, including growth drivers, challenges, emerging trends, and significant developments. The study covers the period from 2024 through 2031, presenting valuable information for stakeholders to make informed decisions and develop strategic plans.

The global orthopedic veterinary implants market is anticipated to grow at a CAGR of 9% during the forecast period, with the market expected to reach a value of USD 5.3 billion by 2031, up from an estimated USD 2.9 billion in 2024.

Key Insights:

  • Orthopedic Veterinary Implants Market Size (2024 Estimate): USD 2.9 Billion
  • Projected Market Value (2031 Forecast): USD 5.3 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 9%

Orthopedic Veterinary Implants Market - Report Scope:

The rising pet ownership and the increasing willingness of pet owners to invest in advanced veterinary care are key drivers of the orthopedic veterinary implants market. As pet owners seek high-quality medical treatments for their animals, there is a growing demand for orthopedic implants to treat conditions like fractures, joint disorders, and degenerative diseases. Technological advancements in implant design and materials have led to more effective treatments, which is boosting the market.

Additionally, the veterinary industry's focus on providing specialized care has created a greater need for skilled orthopedic surgeons and advanced equipment, fostering the development of new products and treatment methods. Furthermore, the increase in veterinary clinics and hospitals offering orthopedic services contributes to the market's expansion.

Market Growth Drivers:

Several factors are driving the growth of the orthopedic veterinary implants market. The growing pet population and the humanization of pets are leading more pet owners to seek specialized treatments. This trend is supported by higher disposable incomes, allowing pet owners to afford more complex and expensive procedures.

Technological advancements have also played a crucial role, with innovations in implant materials like titanium and stainless steel, resulting in more durable and biocompatible products. The adoption of minimally invasive surgical techniques is gaining traction, leading to faster recovery times and reduced risks for pets. Moreover, veterinarians and pet owners are becoming more aware of the benefits of orthopedic implants, driving market growth.

Market Restraints:

Despite its growth, the orthopedic veterinary implants market faces challenges. The high cost of orthopedic procedures and implants can be prohibitive for some pet owners, limiting market reach. This is especially true in developing countries where veterinary care is less accessible, and income levels are lower. The limited availability of skilled orthopedic veterinarians is another restraint, as specialized training is required for these complex procedures. Regulatory hurdles related to product approvals and animal welfare concerns can also slow down the market's expansion. Additionally, fluctuations in raw material prices can affect the cost of manufacturing implants, impacting market dynamics.

Market Opportunities:

The orthopedic veterinary implants market offers several opportunities for growth and expansion. Companies can focus on developing cost-effective implants to cater to a broader range of customers, especially in emerging markets. The increasing adoption of pet insurance can also drive market growth by making expensive procedures more affordable for pet owners. Collaborations between veterinary schools, research institutions, and implant manufacturers can lead to the development of innovative products and techniques, fostering market growth. The rising awareness of animal welfare and the demand for high-quality veterinary care are also expected to create new opportunities for market players.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the Orthopedic Veterinary Implants Market?
  • What are the Key Factors Driving the Growth of the Orthopedic Veterinary Implants Market?
  • Which Region Holds the Largest Market Share in the Orthopedic Veterinary Implants Market?
  • Who are the Key Players in the Global Orthopedic Veterinary Implants Market?
  • What Strategies are Adopted by Leading Companies to Sustain Growth in the Orthopedic Veterinary Implants Market?

Competitive Landscape and Business Strategies:

Leading companies in the orthopedic veterinary implants market include DePuy Synthes, BioMedtrix, VetStem Biopharma, and Veterinary Orthopedic Implants, among others. These companies focus on product innovation, quality, and strategic partnerships to maintain their competitive edge.

Strategies such as expanding distribution networks, investing in research and development, and collaborating with veterinary hospitals are commonly employed to drive growth. Companies also focus on providing comprehensive training and support to veterinary professionals to ensure successful implant outcomes.

Key Companies Profiled:

  • Vet Implants
  • scil animal care company GmbH
  • KYON Pharma, Inc.
  • Everost Inc.
  • BioMedtrix, LLC
  • Integra LifeSciences
  • RITA LEIBINGER MEDICAL GmbH & Co. KG
  • B. Braun Melsungen AG

Orthopedic Veterinary Implants Market Segmentation:

Orthopedic Veterinary Implants Market by By Product type

  • Total Knee Replacement
  • Total Hip Replacement
  • Trauma Fixations
  • Tibial Tuberosity Advancement Implants
  • Tibial Plateau Leveling Osteotomy Implants
  • Advanced Locking Plate System
  • Total Elbow Replacement

Orthopedic Veterinary Implants Market By End User

  • Veterinary Hospitals
  • Veterinary Clinics

Orthopedic Veterinary Implants Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunities
  • 3.5. Trends

4. Key Inclusion

  • 4.1. Arthritis in Dogs
  • 4.2. Routine Care in U.S.
  • 4.3. Pet Ownership

5. Global Orthopedic Veterinary Implants Market Value Analysis 2019-2023 and Forecast, 2024-2031

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
    • 6.3.1. Total Knee Replacement (TKR)
    • 6.3.2. Total Hip Replacement (THR)
    • 6.3.3. Trauma Fixations
    • 6.3.4. Tibial Tuberosity Advancement (TTA) Implants
    • 6.3.5. Tibial Plateau Leveling Osteotomy (TPLO) Implants
    • 6.3.6. Advanced Locking Plate System (ALPS)
    • 6.3.7. Total Elbow Replacement (TER)
  • 6.4. Market Attractiveness Analysis By Product Type

7. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
  • 7.4. Market Attractiveness Analysis By End User

8. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia-Pacific
    • 8.3.5. Middle East & Africa
  • 8.4. Market Attractiveness Analysis By Region

9. North America Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 9.3.1. By Country
      • 9.3.1.1. U.S.
      • 9.3.1.2. Canada
    • 9.3.2. By Product Type
    • 9.3.3. By End User
  • 9.4. Market Attractiveness Analysis
  • 9.5. Drivers & Restraints: Impact Analysis

10. Latin America Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 10.3.1. By Country
      • 10.3.1.1. Brazil
      • 10.3.1.2. Mexico
      • 10.3.1.3. Rest of Latin America
    • 10.3.2. By Product Type
    • 10.3.3. By End User
  • 10.4. Market Attractiveness Analysis
  • 10.5. Drivers & Restraints: Impact Analysis

11. Europe Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 11.3.1. By Country
      • 11.3.1.1. Germany
      • 11.3.1.2. U.K.
      • 11.3.1.3. France
      • 11.3.1.4. Italy
      • 11.3.1.5. Spain
      • 11.3.1.6. Poland
      • 11.3.1.7. Russia
      • 11.3.1.8. Rest of Europe
    • 11.3.2. By Product Type
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Drivers & Restraints: Impact Analysis

12. Asia-Pacific Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. China
      • 12.3.1.2. India
      • 12.3.1.3. Japan
      • 12.3.1.4. Australia & New Zealand
      • 12.3.1.5. Rest of Asia-Pacific
    • 12.3.2. By Product Type
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers & Restraints: Impact Analysis

13. Middle East and Africa Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. GCC Countries
      • 13.3.1.2. South Africa
      • 13.3.1.3. Rest of MEA
    • 13.3.2. By Product Type
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers & Restraints: Impact Analysis

14. Competition Analysis

  • 14.1. Competition Dashboard
  • 14.2. Competition Deep Dive
    • 14.2.1. Vet Implants
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Segment Overview
      • 14.2.1.3. Product Offerings
      • 14.2.1.4. Financial Analysis
      • 14.2.1.5. Key Developments
      • 14.2.1.6. Strategy Overview
    • 14.2.2. scil animal care company GmbH
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Segment Overview
      • 14.2.2.3. Product Offerings
      • 14.2.2.4. Financial Analysis
      • 14.2.2.5. Key Developments
      • 14.2.2.6. Strategy Overview
    • 14.2.3. KYON Pharma, Inc.
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Segment Overview
      • 14.2.3.3. Product Offerings
      • 14.2.3.4. Financial Analysis
      • 14.2.3.5. Key Developments
      • 14.2.3.6. Strategy Overview
    • 14.2.4. Everost Inc.
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Segment Overview
      • 14.2.4.3. Product Offerings
      • 14.2.4.4. Financial Analysis
      • 14.2.4.5. Key Developments
      • 14.2.4.6. Strategy Overview
    • 14.2.5. BioMedtrix, LLC
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Segment Overview
      • 14.2.5.3. Product Offerings
      • 14.2.5.4. Financial Analysis
      • 14.2.5.5. Key Developments
      • 14.2.5.6. Strategy Overview
    • 14.2.6. Integra LifeSciences
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Segment Overview
      • 14.2.6.3. Product Offerings
      • 14.2.6.4. Financial Analysis
      • 14.2.6.5. Key Developments
      • 14.2.6.6. Strategy Overview
    • 14.2.7. RITA LEIBINGER MEDICAL GmbH & Co. KG
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Segment Overview
      • 14.2.7.3. Product Offerings
      • 14.2.7.4. Financial Analysis
      • 14.2.7.5. Key Developments
      • 14.2.7.6. Strategy Overview
    • 14.2.8. B. Braun Melsungen AG
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Segment Overview
      • 14.2.8.3. Product Offerings
      • 14.2.8.4. Financial Analysis
      • 14.2.8.5. Key Developments
      • 14.2.8.6. Strategy Overview
    • 14.2.9. DePuy Synthes (Sub. Johnson & Johnson Services, Inc.)
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Segment Overview
      • 14.2.9.3. Product Offerings
      • 14.2.9.4. Financial Analysis
      • 14.2.9.5. Key Developments
      • 14.2.9.6. Strategy Overview
    • 14.2.10. Intrauma S.p.A.
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Segment Overview
      • 14.2.10.3. Product Offerings
      • 14.2.10.4. Financial Analysis
      • 14.2.10.5. Key Developments
      • 14.2.10.6. Strategy Overview
    • 14.2.11. Surgical Holdings
      • 14.2.11.1. Company Overview
      • 14.2.11.2. Segment Overview
      • 14.2.11.3. Product Offerings
      • 14.2.11.4. Financial Analysis
      • 14.2.11.5. Key Developments
      • 14.2.11.6. Strategy Overview
    • 14.2.12. Ortho Max Manufacturing Company Pvt. Ltd. Novartis AG
      • 14.2.12.1. Company Overview
      • 14.2.12.2. Segment Overview
      • 14.2.12.3. Product Offerings
      • 14.2.12.4. Financial Analysis
      • 14.2.12.5. Key Developments
      • 14.2.12.6. Strategy Overview

15. Assumptions and Acronyms Used

16. Research Methodology